title: Regulation of human gene therapy.
authors.forename: G A
authors.initials: GA
authors.lastname: Chase
authors.forename: P A
authors.initials: PA
authors.lastname: DeLeon
authors.forename: K R
authors.initials: KR
authors.lastname: Dronamraju
authors.forename: R P
authors.initials: RP
authors.lastname: Erickson
authors.forename: J C
authors.initials: JC
authors.lastname: Glorioso
authors.forename: R
authors.initials: R
authors.lastname: Hirschhorn
authors.forename: M T
authors.initials: MT
authors.lastname: Lysaught
authors.forename: K M
authors.initials: KM
authors.lastname: McGraw
authors.forename: A S
authors.initials: AS
authors.lastname: Meyers
authors.forename: A D
authors.initials: AD
authors.lastname: Miller
mesh_terms: D026683:Advisory Committees; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic / Q000331:legislation & jurisprudence; D017322:Clinical Trials, Phase II as Topic / Q000331:legislation & jurisprudence; D004274:DNA, Recombinant; D026724:Ethical Review; D035082:Federal Government; D015316:Genetic Therapy / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States
chemical_list: D004274:DNA, Recombinant